Quantcast
Last updated on April 17, 2014 at 9:26 EDT

Latest Artificial heart Stories

2012-08-08 18:21:55

THE WOODLANDS, Texas, Aug. 9, 2012 /PRNewswire/ -- Berlin Heart announced today that a study published in the current issue of the New England Journal of Medicine (NEJM) concludes that survival using the Company's EXCOR(®) Pediatric Ventricular Assist Device (VAD) is "significantly greater" than the standard-of-care (extracorporeal membrane oxygenation, or "ECMO") as a "bridging therapy" for children in need of a heart transplant. The principal author, Charles D. Fraser, Jr., M.D.,...

2012-08-06 10:23:49

THE WOODLANDS, Texas, Aug. 6, 2012 /PRNewswire/ -- The Berlin Heart Group announced today that the FDA has granted approval for their Post Approval Study, a condition of the "Humanitarian Device Exemption" (HDE) approval that Berlin Heart received for the EXCOR(®) Pediatric Ventricular Assist Device (VAD) on December 16(th), 2011. (Logo: http://photos.prnewswire.com/prnh/20120806/DA52722LOGO) The Berlin Heart EXCOR® Pediatric VAD is a mechanical cardiac support system for critically...

2012-08-06 02:25:38

BERLIN, August 6, 2012 /PRNewswire/ -- - Cross reference: Picture is available at epa european pressphoto agency (http://www.epa.eu) and http://www.presseportal.de/pm/63857 - For the first time in the history of Japan it was possible for doctors at the University of Tokyo, on August 2, 2012, to save a small child who was seriously suffering from a severe heart condition, aided by a Berlin Heart EXCOR(R) ventricular assist device. From a medical point of view the...

2012-08-01 02:28:28

TUCSON, Ariz., Aug. 1, 2012 /PRNewswire/ -- Hiking up to six miles every day isn't for the faint of heart. Luckily for Chris Marshall, he doesn't have one. Marshall, the first SynCardia temporary Total Artificial Heart patient in the Pacific Northwest to leave the hospital using the Freedom® portable driver, has logged more than 400 miles of hiking since being discharged from University of Washington Medical Center on March 29. (Photo: http://photos.prnewswire.com/prnh/20120801/LA50039)...

2012-07-25 02:31:04

TUCSON, Ariz., July 25, 2012 /PRNewswire/ -- On Sept. 20, 2011, 39-year-old Shawn Galloway was given new life when she received a donor heart transplant after 60 days of support with the SynCardia temporary Total Artificial Heart. This September, Galloway and her family will be blessed with new life for a second time. (Photo: http://photos.prnewswire.com/prnh/20120725/LA45946) "We are in the process of adopting a baby," said Galloway, who has a 9-year-old daughter. "Our baby girl is due...

2012-07-19 02:26:13

TUCSON, Ariz., July 19, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that among the top 50 centers honored in U.S. News & World Report's "Best Hospitals" list for cardiology and heart surgery, 15 are certified to implant the SynCardia temporary Total Artificial Heart, five are currently completing certification and an additional five...

2012-07-11 02:25:11

TUCSON, Ariz., July 11, 2012 /PRNewswire/-- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart. (Photo: http://photos.prnewswire.com/prnh/20120711/LA38332) "If I didn't have this device, I probably would have ended up...

2012-06-28 10:25:36

LOS ANGELES, June 28, 2012 /PRNewswire-USNewswire/ -- The UCLA Heart Transplant Program performed its 2,000th heart transplant surgery earlier this month, becoming the first program in the western United States and only the second in the world to achieve this remarkable milestone. Bill Meadows, 59, of Riverside, Calif., who suffered from advanced dilated cardiomyopathy with secondary pulmonary hypertension, received the donated organ on June 4 in a four-hour surgery at Ronald Reagan...

2012-06-26 02:27:43

TUCSON, Ariz., June 26, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that U.S. News & World Report has named three pediatric centers that offer the SynCardia temporary Total Artificial Heart among the nation's Top 10 "Best Children's Hospitals" for Cardiology and Heart Surgery in its annual list. The Children's Hospital of Philadelphia (CHOP)...

2012-06-20 02:26:59

TUCSON, Ariz., June 20, 2012 /PRNewswire/ -- On June 18, SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, was honored with two Gold Stevie® Awards at the 10th Annual American Business Awards. SynCardia won "Company of the Year - Health Products and Services" and "Most Innovative Company of the Year - up to 100 Employees." (Photo: http://photos.prnewswire.com/prnh/20120620/LA27527)...


Latest Artificial heart Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »